The potential of digital twin technology is growing within the clinical trials landscape. Image credit: Gorodenkoff via ShutterStock.com. In recent years, automation and artificial intelligence (AI) ...

At OCT DACH 2025, industry members noted that the implementation of AI in clinical trials must be carefully thought out.

Alkermes announced that the drug met its dual primary endpoints, however this was only in the two high dose cohorts and the data was “adjusted for multiplicity”. Image credit: MediaNews Group / Boston ...

If Roche's fenebrutinib got the FDA go-ahead, it would become the first BTK inhibitor to gain approval in both RMS and PPMS.

Gene anticipates filing a biologics licence application (BLA) for detalimogene voraplasmid to the FDA in H2 2026.

Novo Nordisk said that the data suggests that the benefits of Wegovy go further than just weight loss in the patient population. Image credit: PJ McDonnell / Shutterstock.com. Novo Nordisk’s oral ...

Centessa is advancing ORX750 to pivotal trials based on the Phase IIa data. Image credit: SOPA Images /LightRocket via Getty Images Centessa Pharmaceuticals executives will be breathing a sigh of ...

Despite the trial failure, Sarepta will still seek full approval of AMONDYS 45 and VYONDYS 53 in DMD from the FDA.

Moderna will discontinue the development of mRNA-1647 in CMV after the trial failure. Image credit: Tada Images / Shutterstock.com. Moderna is terminating the development of an mRNA vaccine in ...

Lilly is continuing with its goal of submitting for approval of orforglipron in obesity by the end of 2025, and in type 2 diabetes in 2026. Image credit: Tada Images / Shutterstock.com Eli Lilly’s ...

Comprehensive exploratory biomarker analyses were performed in the 3mg and 5mg multiple ascending dose cohorts. Credit: PeopleImages/Shutterstock.com. Ovid ...

The trial’s objective is to assess ENV105 in men who have progressed after standard hormone-based treatments. Credit: Korawat photo shoot/Shutterstock.com. Kairos Pharma has reported encouraging ...